Suchergebnisse - "Subramanian, Sreedhar"

PubPharm (7)

1

A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE) : a multicentre, open-label randomised controlled trial

enthalten in: The lancet. Gastroenterology & hepatology | 2024

von Noor, N. | Lee, J. | Bond, S. | +40

2

Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite) : an open-label, multicentre, randomised controlled trial

enthalten in: The lancet. Gastroenterology & hepatology | 2024

von Lindsay, J. | Hind, D. | Swaby, L. | +30

3

Genome-Wide Methylation Profiling in 229 Patients With Crohn's Disease Requiring Intestinal Resection : Epigenetic Analysis of the Trial of Prevention of Post-operative Crohn's Disease (TOPPIC)

enthalten in: Cellular and molecular gastroenterology and hepatology | 2023

von Ventham, N. | Kennedy, N. | Kalla, R. | +103

4

Randomized Trial of Ciprofloxacin Doxycycline and Hydroxychloroquine Versus Budesonide in Active Crohn's Disease

enthalten in: Digestive diseases and sciences | 2021

von Rhodes, J. | Subramanian, S. | Flanagan, P. | +10

CommentIn: Dig Dis Sci. 2021 Aug;66(8):2478-2480. - PMID 32880798

5

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative Colitis

enthalten in: Inflammatory bowel diseases | 2018

von Irving, P. | Iqbal, T. | Nwokolo, C. | +9

6

Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC) : a multicentre, double-blind, randomised controlled trial

enthalten in: The lancet. Gastroenterology & hepatology | 2016

von Mowat, C. | Arnott, I. | Cahill, A. | +41

CommentIn: Lancet Gastroenterol Hepatol. 2017 Feb;2(2):81. - PMID 28403990

7

Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis

enthalten in: Gut | 2011

von Leiper, K. | Martin, K. | Ellis, A. | +6

CommentIn: Gut. 2012 Feb;61(2):327. - PMID 21613645

1
[1]